Editorial aging" theory [4] ) and the expression of RAGE on many cell membranes, even in the absence of a pathological event, could favour low-grade, persistent, pro-inflammatory processes which in turn could drive increased production of DAMPs and expression of RAGE. This pro-aging vicious circle of events places RAGE firmly in the spotlight as a key-actor in inflammaging, not least because senescent cells also produce RAGE ligands like HMGB1 and S100s. This hypothesis is attractive and opens up significant possibilities in the development of anti-RAGE therapeutics, but many questions remain. To what extent do the different RAGE ligands compete for binding, and how does this competition modulate its activation? Are the activated signalling pathways ligand-specific, or perhaps specific to the configuration of RAGE in its homodimeric, oligomeric or proposed heterodimeric (eg. with TLRs) forms? Are there negative effects to RAGE inhibition? Indeed, the physiological roles of RAGE remain to be fully elucidated. Its depletion is not lethal and RAGE knockout mice develop normally without evident defects or reduced fertility. In human adults, its expression becomes weak in most tissues at a basal state. However, RAGE is conserved across mammal species and its high constitutive and ubiquitous expression in embryonic life suggests it might be important in early development. Interestingly, it has recently been cited as a key player in the immunometabolic networks controlling responses to nutrient supply in a mouse model of adipocyte-specific RAGE deletion [5] . The authors proposed that RAGE's primal endogenous function could belong to the "thrifty genotype", and that its innate mechanism is the suppression of adipocyte metabolism and energy expenditure, perhaps partly explaining its preservation through evolution. Further, most detrimental effects of RAGE stimulation are prominent mostly during post-reproductive life, but some isoforms do not have an entirely negative impact: nuclear RAGE has been implicated in DNA repair [6] , while both the endogenous secretory RAGE (esRAGE) and the cleaved RAGE (cRAGE) -two forms of soluble RAGE (sRAGE) -can serve as a decoy for RAGEligands and/or interact with FL-RAGE to block its intracellular signalling. Notably, an age-related decrease of circulating cRAGE has been reported in healthy www.aging-us.com AGING 2019, Vol. 11, No. 17
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humans which was inversely correlated with inflammatory markers [7] . This could indicate a reduced capacity with age to bind ligands such as DAMPs, thus favouring inflammaging and age-related diseases. A murine model overexpressing circulating sRAGE has recently been generated [8] and may help to investigate the relationship between different RAGE isoforms and inflammaging.
The driving mechanisms of aging remain to be fully elucidated. Multiple theories have been proposed which more or less support the thesis of a programmed process -it seems likely that no single factor is responsible, but rather a combination of factors, occurring in an adaptive manner, defines individual aging. We are firmly of the opinion RAGE is involved in the course of aging. With its dynamically-regulated expression and multi-faceted role throughout an organism's lifespan, it could well be included in antagonistic pleiotropy theories. Perhaps RAGE could even be more generally considered as a receptor that participates in selection for healthy aging. RAGE's functions are undeniably and fascinatingly complex -much work remains to decipher its role in aging, to provide a more complete vision of this receptor's role in healthspan, and to understand how to advantageously modulate its activation for successful aging.
